Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FFAR1 Antikörper (3rd Extracellular Loop)

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch FFAR1 in WB, IF, IHC, FACS und LCI. Es zeigt Reaktivität gegenüber Proben von Ratte.
Produktnummer ABIN7886323
1.184,62 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für FFAR1 Antikörper (3rd Extracellular Loop) (ABIN7886323)

Target

Alle FFAR1 Antikörper anzeigen
FFAR1 (Free Fatty Acid Receptor 1 (FFAR1))

Reaktivität

  • 56
  • 31
  • 15
  • 5
  • 5
  • 3
  • 1
Ratte

Wirt

  • 56
  • 1
Kaninchen

Klonalität

  • 57
Polyklonal

Konjugat

  • 22
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser FFAR1 Antikörper ist unkonjugiert

Applikation

  • 43
  • 17
  • 13
  • 13
  • 8
  • 6
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Bindungsspezifität

    • 15
    • 8
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    3rd Extracellular Loop, AA 244-259

    Verwendungszweck

    A Rabbit Polyclonal Antibody to Free Fatty Acid Receptor 1 (GPR40)

    Homologie

    16 amino acid residues identical,Mouse - 15, human - 12

    Produktmerkmale

    Anti-GPR40/FFAR1 (extracellular) Antibody (ABIN7043137, ABIN7044279 and ABIN7044280) is a highly specific antibody directed against an epitope of the rat Free fatty acid receptor 1. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize FFAR1 from mouse, rat, and human samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    (C)NVASFINPDLEGSWRK corresponding to amino acid residues 244-259 of rat FFAR1

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:200

    FC: 2.5 μg per reaction

    ICC: The optimal concentration should be determined by the user

    IHC: The optimal concentration should be determined by the user

    IP: The optimal concentration should be determined by the user

    Kommentare

    Cited Application: IHC

    Negative Control: (ABIN7235329)

    Blocking Peptide: (ABIN7235329)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Konzentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    FFAR1 (Free Fatty Acid Receptor 1 (FFAR1))

    Andere Bezeichnung

    FFAR1

    Hintergrund

    Synonyms: G-protein coupled receptor 40, Free fatty acid receptor 1

    Description: Free fatty acids (FFAs) were for long believed to influence cellular metabolism. Hoever, the discovery that FFAs actually mediate their effects through one of three G-protein coupled receptors (GPCRs) - Free Fatty Acid Receptors 1-3 (FFAR1-3), has initiated a number of studies in order to assess their implication in health and disease1.Like all other GPCRs, FFAR1-3 have seven transmembrane domains, an extracellular N-terminal tail and an intracellular C-terminus.FFAR1 is activated by either medium or long, saturated or unsaturated fatty acids2,3, whereas FFAR2 and FFAR3 are activated by short chain fatty acids4,5. FFAR1 is coupled to Gq and leads to Ca2+ mobilization upon activation. FFAR2 couples to both pertussis-sensitive and insensitive G-proteins and also leads to increased intracellular Ca2+ levels. FFAR3 coupling to G-protein induces an increase in cAMP1.Distribution studies of all three FFA Receptors indicate that FFAR1 mRNA is quite elevated in the pancreas2,3. FFAR1 is also detected in the liver, heart, skeletal muscle, and brain, although this broad localization pattern is supported only by one study2. FFAR2 is expressed in many tissues like liver and colon6. FFAR3 is expressed in many tissues but shows highest expression in adipose tissue4. Relatively high expression of the receptor could be detected in pancreas, spleen, lymph nodes and bone marrow4,5.As mentioned above, the finding that FFAs' actions are mediated by GPCRs, prompted many studies in order to elucidate their roles in healthy and disease states. Such studies stipulate that FFAR1 may be involved in obesity and type 2 diabetes since circulating free fatty acid levels in the plasma are significantly elevated. On the other hand, FFAR2 and FFAR3 could be potential targets for treating irritable bowel disease and appetite control1.

    Gen-ID

    266607

    NCBI Accession

    NM_005303

    UniProt

    Q8K3T4

    Pathways

    Positive Regulation of Peptide Hormone Secretion, Hormone Transport, Peptide Hormone Metabolism, Carbohydrate Homeostasis
Sie sind hier:
Chat with us!